Register entry
Pacira Pharmaceuticals, Inc.
- Registered sites
- 1
- Drug products
- 3
- Live patents
- 44
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Pacira Pharmaceuticals, Inc. | San Diego, CAUnited States | Analytical testing, Finished drug manufacture | 3002783962 |
Exclusivity
Patents
44Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| EXPAREL | BUPIVACAINE | Jan 2041 |
| EXPAREL | BUPIVACAINE | Mar 2042 |
| EXPAREL | BUPIVACAINE | Feb 2043 |
| EXPAREL | BUPIVACAINE | Jul 2044 |
| ZILRETTA | TRIAMCINOLONE ACETONIDE | Aug 2031 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| EXPAREL | bupivacaine | INJECTION, SUSPENSION, LIPOSOMAL | NDA |
| EXPAREL | bupivacaine | INJECTION, SUSPENSION, LIPOSOMAL | NDA |
| Zilretta | triamcinolone acetonide extended-release injectable suspension | KIT | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.